Stellungnahme – Kombinierte Hormonersatztherapie – ein Risiko für demenzielle Erkrankungen?

Eine im Juni 2023 veröffentlichte Studie zum Thema kombinierte Hormonersatztherapie und Demenzrisiko wird in der nachfolgend wiedergegebenen Stellungnahme wegen biologisch und klinisch nicht plausibler Assoziationen kritisch betrachtet.

• Literatur

• 1 Pourhadi N, Mørch LS, Holm EA. et al. Menopausal hormone therapy and dementia: nationwide, nested case-control study. BMJ 2023; 381: e072770
• 2 Savolainen-Peltonen H, Rahkola-Soisalo P, Hoti F. et al. Use of postmenopausal hormone therapy and risk of Alzheimerʼs disease in Finland: nationwide case-control study. BMJ 2019; 364: l665
• 3 Mikkola TS, Savolainen-Peltonen H, Tuomikoski P. et al. Lower Death Risk for Vascular Dementia Than for Alzheimerʼs Disease With Postmenopausal Hormone Therapy Users. JCEM 2017; 102: 870-877
• 4 Shumaker SA, Legault C, Rapp SR. et al. WHIMS Investigators. Estrogen plus progestin and the incidence of dementia and mild cognitive impairment in postmenopausal women: the Womenʼs Health Initiative Memory Study: a randomized controlled trial. JAMA 2003; 289: 2651-2662
• 5 Espeland MA, Shumaker SA, Leng I. et al. WHIMSY Study Group. Long-term effects on cognitive function of postmenopausal hormone therapy prescribed to women aged 50 to 55 years. JAMA Intern Med 2013; 173: 1429-1436
• 6 Vinogradova Y, Dening T, Hippisley-Cox J. et al. Use of menopausal hormone therapy and risk of dementia: nested case-control studies using QResearch and CPRD databases. BMJ 2021; 374: n2182
• 7 Matyi JM, Rattinger GB, Schwartz S. et al. Lifetime estrogen exposure and cognition in late life: the Cache County Study. Menopause 2019; 26: 1366-1374
• 8 Shao H, Breitner JC, Whitmer RA. et al. Cache County Investigators. Hormone therapy and Alzheimer disease dementia: new findings from the Cache County Study. Neurology 2012; 79: 1846-1852
• 9 Bagger YZ, Tankó LB, Alexandersen P. et al. PERF Study Group. Early postmenopausal hormone therapy may prevent cognitive impairment later in life. Menopause 2005; 12: 12-17
• 10 Henderson VW. Alzheimerʼs disease: review of hormone therapy trials and implications for treatment and prevention after menopause. J Steroid Biochem Mol Biol 2014; 142: 99-106
• 11 Hersi M, Irvine B, Gupta P. et al. Risk factors associated with the onset and progression of Alzheimerʼs disease: A systematic review of the evidence. Neurotoxicology 2017; 61: 143-187
• 12 Ilomaki J, Jokanovic N, Tan EC. et al. Alcohol Consumption, Dementia and Cognitive Decline: An Overview of Systematic Reviews. Curr Clin Pharmacol 2015; 10: 204-212
• 13 Peters R, Peters J, Warner J. et al. Alcohol, dementia and cognitive decline in the elderly: a systematic review. Age Ageing 2008; 37: 505-512
• 14 Kantarci K, Manson JE. Menopausal hormone therapy and dementia. BMJ 2023; 381: 1404